Impedimed (ASX:IPD)
ASX announcement history & article coverage
Transparent by design.
Announcments by Impedimed (ASX:IPD) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 4G and Corporate Governance Statement
2026 Annual Report
ImpediMed reports 15% revenue growth, expands SOZO platform, completes $15.3M capital raise
Appendix 4E
FDA Clearance for Sarcopenia Risk Assessment Received
ImpediMed's SOZO Platform Gains FDA Clearance for Sarcopenia Risk Assessment
ASX Listing Rule 7.16 Compliance
Notification of cessation of securities - IPD
Investor Presentation
Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
ImpediMed reports Q4 FY26 revenue growth, $15.3 million capital raise, and strategic progress in cancer survivorship and heart health
Notification of Q4 FY26 Quarterly Results Investor Webinar
Notification of cessation of securities - IPD
Change of Director's Interest Notice - Mr Andrew Grant
Change of Director's Interest Notice - Ms Emmanuel-Donnelly
Change of Director's Interest Notice - Ms Janelle Delaney
Change of Director's Interest Notice - Ms Fiona Bones
Change of Director's Interest Notice - Mr Erik Anderson
Application for quotation of securities - IPD
Notification of cessation of securities - IPD
Ceasing to be a substantial shareholder from AEF
Notification regarding unquoted securities - IPD
Update on Options and Holding Statements
Change in substantial holding
Change in substantial shareholding from AEF
Change in substantial holding
Change in Substantial Shareholding from AEF
Change of Director's Interest Notice - Mr Andew Grant
Change of Director's Interest Notice - Ms Emmanuel-Donnelly
Change of Director's Interest Notice - Ms Janelle Delaney
Change of Director's Interest Notice - Ms Fiona Bones
Change of Director's Interest Notice - Mr Erik Anderson
Top 20 Quoted Option Holders and Distribution Schedule
Notice under Section 708A(5)(e) of the Corporations Act
Application for quotation of securities - IPD
Results of Extraordinary General Meeting
Oversubscribed Share Purchase Plan Successfully Completed
ImpediMed completes oversubscribed $2.1 million Share Purchase Plan following $13.2 million placement
Change of Director's Interest Notice - Mr Erik Anderson
Change of Director's Interest Notice - Ms Fiona Bones
Change of Director's Interest Notice - Ms Janelle Delaney
Change of Director's Interest Notice - Ms Emmanuel-Donnelly
Change of Director's Interest Notice - Mr Andrew Grant
Application for quotation of securities - IPD